Commission’s D’Acunto Tells EU Industry To Talk Less About Bottlenecks
The medical technology industry has lobbied the European Commission hard because it believes the time it has to comply with the new Medical Device and IVD Regulations is much too short and threatens product availability. But the commission has hit back at these claims.
You may also be interested in...
Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.
Transparency linked to new device registration rules will provide new market analysis possibilities. Medtech Insight delved deeper into the benefits of the European Medical Device Nomenclature with two Italian executives who see its potential.
The hope is now that a new EU document will be issued to address head on the scale of bottlenecks at notified bodies and of products needing to be removed from the market.